Details of the Drug

General Information of Drug (ID: DM7A92T)

Drug Name
AVTX-002
Synonyms quisovalimab
Indication
Disease Entry ICD 11 Status REF
Non-eosinophilic asthma CA23 Phase 2 [1]
Drug Type
Antibody
Cross-matching ID
UNII
M46KZB8QXL
DrugBank ID
DB16482
TTD ID
DBU4N1

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Herpes virus entry mediator ligand (CD258) TTKVENM TNF14_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05288504) A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Avalo Therapeutics